课题基金 / 基金详情

Interaction between ion channels and membrane skeleton

Interaction between ion channels and membrane skeleton
离子通道与膜骨架之间的相互作用
批准号:
03833019
负责人:
INUI Makoto
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

INUI Makoto的其他基金

相似基金

相关文献

中文摘要
翻译
膜骨架在许多生物过程中起着至关重要的作用,包括膜受体的动员、内吞作用、胞吐作用、细胞极性和形态、细胞粘附和膜脂周转。Ca^<2+>对多种细胞的膜骨架具有深远的影响,一定存在着Ca^<2+>对膜骨架蛋白的调控系统。由于Ca^<2+>通过Ca^<2+>通道进入细胞,因此Ca^<2+>通道与膜骨架之间可能存在功能性相互作用。在本研究中,我们重点研究了脑中Ca^<2+> -和磷脂结合蛋白膜联蛋白VI,并研究了膜联蛋白VI是否参与Ca^<2+>对膜骨骼蛋白的调节。膜联蛋白VI以Ca^<2+>/磷脂依赖的方式与大鼠脑全浆中约14种蛋白结合。其中,细胞骨架部分富集了5种蛋白,其中1种被鉴定为脑谱蛋白(calspectin)。当用天然状态纯化的钙蛋白蛋白检测时,膜联蛋白VI与钙蛋白蛋白的结合也依赖于Ca^<2+> -。结合体的Ca^<2+>亲和力(KCa)约为20 muM。对膜联蛋白VI的亲和力(Kd)约为270 nM。膜联蛋白VI与钙蛋白的β亚基结合,但不与α亚基结合。当用低剪切粘度法检测膜联蛋白VI对f -肌动蛋白与钙蛋白相互作用的影响时,膜联蛋白VI以Ca^<2+>/磷脂依赖的方式抑制了钙蛋白的f -肌动蛋白交联活性。共沉淀实验表明,只有在Ca^<2+>和磷脂存在的情况下,膜联蛋白VI才能将钙蛋白与f -肌动蛋白分离。这些结果表明,膜联蛋白VI可以在质膜下以Ca2+/磷脂依赖的方式解离和重新分配钙蛋白,并且膜联蛋白VI可能通过响应Ca^<2+ bb0来调节神经元细胞的膜骨架。
英文摘要
The membrane skeleton plays a critical role in a number of biological processes including mobilization of membrane receptors, endocytosis, exocytosis, cell polarity and morphology, cell adhesion, and membrane lipid turnover. Ca^<2+> has profound effects on the membrane skeleton in a variety of cells, and there must exist regulation system(s) of the membrane skeletal proteins by Ca^<2+>. Since Ca^<2+> comes into cells through Ca^<2+> channels, there may be functional interaction between Ca^<2+> channels and the membrane skeleton. In the present study, we focused on a Ca^<2+> - and phospholipid-binding protein, annexin VI, in brain, and examined whether annexin VI is involved in the regulation of membrane skeletal proteins by Ca^<2+>. Annexin VI bound to about 14 proteins in rat brain whole homogenate in a Ca^<2+>/phospholipid-dependent manner. Of these, 5 proteins were enriched in the cytoskeletal fraction, and one of them was identified to be calspectin (brain spectrin or fodrin). When examined with purified calspectin in the native state, the binding of annexin VI to calspectin was also Ca^<2+> - dependent. The Ca^<2+> affinity of the binding (KCa) was about 20 muM. The affinity for annexin VI (Kd) was about 270 nM. Annexin VI bound to beta subunit of calspectin but not to alpha subunit. When the effect of annexin VI on the interaction between F-actin and calspectin was examined by low-shear viscometry, annexin VI inhibited the F-actin cross-linking activity of calspectin in a Ca^<2+>/phospholipid-dependent manner. Cosedimentation assay showed that annexin VI dissociates calspectin from F-actin only in the presence of Ca^<2+> and phospholipid. These results indicate that annexin VI can dissociate and redistribute calspectin in a Ca2+/phospholipid-dependent manner under the plasma membrane, and that annexin VI may regulate the membrane skeleton of neuronal cells in response to Ca^<2+>.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanaka,T.: "Ca^<2+>ーDependent of the spectrin/actin interaction by calmodulin and protein 4.1." J.Biol.Chem.266. 1134-1140 (1991)
Tanaka, T.:“Ca^<2+> - 钙调蛋白和蛋白质 4.1 影响血影蛋白/肌动蛋白相互作用。J.Biol.Chem.266 (1991)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 16 条
    Ultrastructural analysis of calcium transport system of cardiac sarcoplasmic reticulum for drug development
    • 批准号:
      17H04033
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.48万
    • 财政年份:
      2017
    • 负责人:
      INUI Makoto
    • 依托单位:
    Elucidation of the molecular mechanisms by a cyclic peptide, SEK-1005 promotes skin wound healing
    • 批准号:
      16K15203
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.25万
    • 财政年份:
      2016
    • 负责人:
      INUI Makoto
    • 依托单位:
    Analysis of IGF-1 receptor-independent signaling from IGF-1 and its application for drug development
    • 批准号:
      25670128
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      INUI Makoto
    • 依托单位:
    Development of a new drug for heart failure targeting phospholamban
    • 批准号:
      25293062
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2013
    • 负责人:
      INUI Makoto
    • 依托单位:
    海外基金